Augmenta Bioworks
Augmenta Bioworks is dedicated to building global immunity to disease by harnessing natural human immunity to discover new therapeutics. They utilize advanced molecular biology, automation, microfluidics, high throughput DNA sequencing, and computational analysis to identify immune receptors and their antigen specificity, guiding the development of new therapies. They collaborate with pharmaceutical companies, biotech firms, and research institutions to improve vaccine efficacy, discover new antibodies, and develop cell therapies.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Immune repertoire analysis platform
An integrated discovery platform that combines microfluidics, high-throughput sequencing, laboratory automation, and large-scale computational analysis to identify immune receptors and their antigen specificities.
Immune repertoire analysis platform
An integrated discovery platform that combines microfluidics, high-throughput sequencing, laboratory automation, and large-scale computational analysis to identify immune receptors and their antigen specificities.
Services
Collaborative research partnerships to apply immune repertoire profiling and discovery tools to therapeutic programs.
Services to profile changes in immune repertoires after antigen exposure or therapeutic intervention to inform vaccine and immunotherapy programs.
Collaborative research partnerships to apply immune repertoire profiling and discovery tools to therapeutic programs.
Services to profile changes in immune repertoires after antigen exposure or therapeutic intervention to inform vaccine and immunotherapy programs.
Expertise Areas
- Immune repertoire analysis
- Antibody discovery from human repertoires
- Cell therapy target discovery
- Vaccine immunomonitoring
Key Technologies
- Next-generation sequencing
- Microfluidics
- Laboratory automation
- Scalable bioinformatics and computational analysis